Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

Multicenter, Non-comparative, Open-label Study to Evaluate the Safety and Efficacy of Enoxaparin Sodium (RP54563) 20 mg Bid for 14 Days in Patients With Hip Fracture Surgery

The purpose of this study is to evaluate the effects of enoxaparin on bleeding and venous blood clots in patients with hip fracture surgery.

Inclusion Criteria:

• femoral neck inside or outside fracture

Exclusion Criteria:

• any major surgery on lower limbs within 3 months
• clinical signs of deep vein thrombosis
• use of non-steroidal anti-inflammatory drugs
• severe hepatic disease or renal insufficiency